- Moderna gets further $472 million U.S. award for coronavirus vaccine developmentYahoo Finance
- 5 Late-Stage COVID-19 Vaccines: Which Is Likely to Be the Biggest Winner?Motley Fool
- Big Pharma and the cost of developing COVID-19 drugs and vaccines | Counting the CostAl Jazeera English
- Covid-19 is Big Pharma’s chance to impress. But who’ll do best?The Guardian
- Trump administration invests $472M more in Moderna vaccine candidatePOLITICO
- View Full Coverage on Google News